Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Latent Tuberculosis

• 1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam
• TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
• Short-course Regimens for the Treatment of Pulmonary Tuberculosis
• The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in Patients With Kidney Transplantation: a Prospective Intervention Pilot Study
• A Phase 1, Drug-Drug Interaction Study to Evaluate Safety, Tolerability, and Induction Potential of TBAJ-876 on CYP3A4 and P-glycoprotein and Inhibition Potential of TBAJ-876 on P-glycoprotein in Healthy Adults
• Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy
• Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention
• One-month Latent Tuberculosis Treatment for Renal Transplant Candidates
• BCG Revaccination in Children and Adolescents
• Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV
• Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
• Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens Into the Human Lung
• Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease
• Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation
• Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis
• Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
• Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
• Immunization With BCG Vaccine to Prevent Tuberculosis Infection
• Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation
• A Multicentre, Cohort Study of Screening and Preventive Intervention for Latent Tuberculosis Infection in Children
• Risk of SDRs Under 3HP and 1HP Regimen for LTBI
• 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.
• Doravirine, Rifapentine and Isoniazid Interaction
• Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals
• Tuberculosis Clinical Trials Consortium Study 35
• Evaluation of Diabetes Control and Effect on Transmission and Development of Tuberculosis
• Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
• Treatment of Latent Tuberculosis in Socially Marginalised Citizens
• Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted With Cobicistat in Healthy Volunteers
• Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women
• Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan
• Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)
• "Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients".
• Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
• Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
• Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)
• QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study.
• Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination
• Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness
• Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits
• Vitamin D in Active Tuberculosis (TB) Study
• Vitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Latent Tuberculosis
• Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
• Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection
• Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers
• Treatment of Latent Tuberculosis Infection With Isoniazid
• Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)
• Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection